
Feb 3 (Reuters) - Amgen Inc AMGN.O:
AMGEN OUTLOOK FY26 ADJUSTED EPS $21.60-$23.00 VERSUS IBES ESTIMATE $22.09
AMGEN Q4 ADJUSTED EPS $5.29 VERSUS IBES ESTIMATE $4.73
AMGEN OUTLOOK FY26 TOTAL REVENUE $37.0 BILLION-$38.4 BILLION VERSUS IBES ESTIMATE $37.08 BILLION
AMGEN Q4 TOTAL REVENUE $9.87 BILLION VERSUS IBES ESTIMATE $9.47 BILLION
AMGEN: PHASE 1 STUDY OF AMG 513 ENROLLING ADULTS LIVING WITH OBESITY
AMGEN: TO INITIATE PHASE 3 STUDIES OF MARITIDE IN PEOPLE LIVING WITH TYPE 2 DIABETES IN 2026
AMGEN OUTLOOK FY26 SHARE REPURCHASES NOT TO EXCEED $3 BILLION